Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             250 results found
no title author magazine year volume issue page(s) type
1 Acid-related disorders in the elderly Franceschi, Marilisa
2009
38-39 6 p. 839-848
10 p.
article
2 Action and function of Akkermansia muciniphila in microbiome ecology, health and disease Ottman, Noora
2017
38-39 6 p. 637-642
article
3 Action and function of Chromobacterium violaceum in health and disease: Violacein as a promising metabolite to counteract gastroenterological diseases Justo, Giselle Zenker
2017
38-39 6 p. 649-656
article
4 Action and function of Faecalibacterium prausnitzii in health and disease Ferreira-Halder, Carmen Veríssima
2017
38-39 6 p. 643-648
article
5 Adaptation following intestinal resection: mechanisms and signals Thiesen Jr., A
2003
38-39 6 p. 981-995
15 p.
article
6 Advanced endoscopic imaging for gastric cancer assessment: New insights with new optics? Serrano, M.
2014
38-39 6 p. 1079-1091
13 p.
article
7 Ageing: definitions, mechanisms and the magnitude of the problem Balcombe, Nicholas R
2001
38-39 6 p. 835-849
15 p.
article
8 Aims & Scope/ Editorial Board 2009
38-39 6 p. iii-
1 p.
article
9 Aims & Scope/Editorial Board 2016
38-39 6 p. iii-
1 p.
article
10 Aims & Scope/ Editorial Board 2014
38-39 6 p. iii-
1 p.
article
11 Aims & scope/editorial board 2006
38-39 6 p. iii-
1 p.
article
12 Aims ; scope/editorial board 2004
38-39 6 p. iii-
1 p.
article
13 Aims & scope/Editorial board 2007
38-39 6 p. iii-
1 p.
article
14 Aims & Scope/ Editorial Board 2010
38-39 6 p. iii-
1 p.
article
15 Aims & scope/editorial board 2005
38-39 6 p. iii-
1 p.
article
16 Aims & scope/editorial board 2008
38-39 6 p. iii-
1 p.
article
17 Aims & Scope/ Editorial Board 2015
38-39 6 p. iii-
1 p.
article
18 Aims & Scope/ Editorial Board 2011
38-39 6 p. iii-
1 p.
article
19 Aims & Scope/ Editorial Board 2013
38-39 6 p. iii-
1 p.
article
20 Aims & Scope/ Editorial Board 2012
38-39 6 p. iii-
1 p.
article
21 Alterations confined to the gastro-oesophageal junction: the relationship between low LOSP, TLOSRs, hiatus hernia and acid pocket Boeckxstaens, Guy E.
2010
38-39 6 p. 821-829
9 p.
article
22 Amsterdam and Netherlands gastroenterology: a historical perspective Modlin, Irvin M.
2002
38-39 6 p. 971-998
28 p.
article
23 An algorithm for diagnosis and treatment of refractory GERD Hershcovici, Tiberiu
2010
38-39 6 p. 923-936
14 p.
article
24 A pragmatic symptom-based approach Kuo, Paul
2010
38-39 6 p. 765-773
9 p.
article
25 Assessing and interviewing the elderly: interpretation of signs and symptoms Sklar, Manuel
2001
38-39 6 p. 851-867
17 p.
article
26 Assessment of a cancer screening program Rabeneck, Linda
2015
38-39 6 p. 979-985
7 p.
article
27 Atrophy–metaplasia–dysplasia–carcinoma sequence in the stomach: a reality or merely an hypothesis? Meining, A.
2001
38-39 6 p. 983-998
16 p.
article
28 Autoimmune hepatitis in special patient populations Czaja, Albert J.
2011
38-39 6 p. 689-700
12 p.
article
29 Autoimmune liver disease Manns, Michael P.
2011
38-39 6 p. 641-642
2 p.
article
30 Autoimmune liver diseases in children – What is different from adulthood? Mieli-Vergani, Giorgina
2011
38-39 6 p. 783-795
13 p.
article
31 Biliary tract cancers: From pathogenesis to endoscopic treatment Demols, Anne
2007
38-39 6 p. 1015-1029
15 p.
article
32 Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) Kanakis, George
2012
38-39 6 p. 791-802
12 p.
article
33 Biotherapies for GEP-NETs Öberg, Kjell
2012
38-39 6 p. 833-841
9 p.
article
34 Cancer surveillance in gastroenterology practice Kaminski, Michal F.
2016
38-39 6 p. 853-854
2 p.
article
35 Care of the elderly with gastrointestinal problems in family practice Newton, Julia L.
2001
38-39 6 p. 1013-1025
13 p.
article
36 Changing epidemiology of hepatocellular carcinoma in Asia Goh, George Boon-Bee
2015
38-39 6 p. 919-928
10 p.
article
37 Chemoprevention trials of GI cancers in Asia Li, James Weiquan
2015
38-39 6 p. 967-978
12 p.
article
38 Chronic gastritis – An update Varbanova, Mariya
2014
38-39 6 p. 1031-1042
12 p.
article
39 Chronic viral hepatitis as a public health issue in the world Lavanchy, Daniel
2008
38-39 6 p. 991-1008
18 p.
article
40 Classification, epidemiology and aetiology Koffeman, Geert I
2003
38-39 6 p. 879-893
15 p.
article
41 Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma Ferreira, Rui M.
2014
38-39 6 p. 1003-1015
13 p.
article
42 Colon cancer and the elderly: From screening to treatment in management of GI disease in the elderly Holt, Peter R.
2009
38-39 6 p. 889-907
19 p.
article
43 Colonic and rectal NET's Mandair, Dalvinder
2012
38-39 6 p. 775-789
15 p.
article
44 Colorectal cancer screening Winawer, Sidney J.
2007
38-39 6 p. 1031-1048
18 p.
article
45 Complications of bile-duct stones: acute cholangitis and pancreatitis van Erpecum, Karel J.
2006
38-39 6 p. 1139-1152
14 p.
article
46 Constipation in old age Gallagher, Paul
2009
38-39 6 p. 875-887
13 p.
article
47 Corrigendum to “Current challenges in liver transplantation for hepatocellular carcinoma” [Best Pract Res Clin Gastroenterol 28 (2014) 867–879] Bhoori, Sherrie
2014
38-39 6 p. 1115-1116
2 p.
article
48 Cost-effectiveness of Barrett's oesophagus screening and surveillance Gordon, Louisa G.
2013
38-39 6 p. 893-903
11 p.
article
49 Cost-effectiveness of biological agents used in ulcerative colitis Lee, Jeannie K.
2013
38-39 6 p. 949-960
12 p.
article
50 Cost-effectiveness of liver cancer screening Cucchetti, Alessandro
2013
38-39 6 p. 961-972
12 p.
article
51 Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention Lansdorp-Vogelaar, Iris
2013
38-39 6 p. 933-947
15 p.
article
52 Cost effectiveness of surveillance for GI cancers Omidvari, Amir-Houshang
2016
38-39 6 p. 879-891
13 p.
article
53 Cost-effectiveness of viral hepatitis B & C treatment Toy, Mehlika
2013
38-39 6 p. 973-985
13 p.
article
54 Current trends in the treatment of upper gastrointestinal disease Sachs, George
2002
38-39 6 p. 835-849
15 p.
article
55 Demography of aging and the epidemiology of gastrointestinal disorders in the elderly Goldacre, Michael J.
2009
38-39 6 p. 793-804
12 p.
article
56 Diagnosing portal hypertension Wongcharatrawee, Suchat
2000
38-39 6 p. 881-894
14 p.
article
57 Diagnosis and initial management of Gastroesophageal complications Kamal, Afrin
2010
38-39 6 p. 799-820
22 p.
article
58 Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes Chevaliez, Stéphane
2008
38-39 6 p. 1031-1048
18 p.
article
59 Diagnosis and treatment of hepatic encephalopathy Blei, Andres T
2000
38-39 6 p. 959-974
16 p.
article
60 Diagnosis and treatment of hepatorenal syndrome Ginès, Pere
2000
38-39 6 p. 945-957
13 p.
article
61 Diagnosis of primary biliary cirrhosis Hirschfield, Gideon M.
2011
38-39 6 p. 701-712
12 p.
article
62 Diagnosis, treatment and prevention of spontaneous bacterial peritonitis Fernández, Javier
2000
38-39 6 p. 975-990
16 p.
article
63 Diagnostic criteria for autoimmune hepatitis Lohse, Ansgar W.
2011
38-39 6 p. 665-671
7 p.
article
64 Diet, microbiome, and colorectal cancer Konstantinov, Sergey R.
2017
38-39 6 p. 675-681
article
65 Disease definition, clinical manifestations, epidemiology and natural history of GERD Vakil, Nimish
2010
38-39 6 p. 759-764
6 p.
article
66 Drug metabolism and drug interactions in the elderly Herrlinger, Charlotte
2001
38-39 6 p. 897-918
22 p.
article
67 Drug-related damage of the ageing gastrointestinal tract Sostres, Carlos
2009
38-39 6 p. 849-860
12 p.
article
68 Early diagnosis and treatment of hepatocellular carcinoma Llovet, Josep M
2000
38-39 6 p. 991-1008
18 p.
article
69 Early esophageal cancer screening in China Gao, Qin-Yan
2015
38-39 6 p. 885-893
9 p.
article
70 Economic evaluation of colorectal cancer (CRC) screening Cruzado, José
2013
38-39 6 p. 867-880
14 p.
article
71 Editorial Board 2003
38-39 6 p. iii-
1 p.
article
72 Effective screening for early diagnosis of pancreatic cancer Hanada, Keiji
2015
38-39 6 p. 929-939
11 p.
article
73 Endoscopic detection of early lower gastrointestinal cancer Kiesslich, R.
2005
38-39 6 p. 941-961
21 p.
article
74 Endoscopic detection of early upper GI cancers Wong Kee Song, Louis-Michel
2005
38-39 6 p. 833-856
24 p.
article
75 Endoscopic mucosal resection for early-stage gastrointestinal cancers Inoue, Haruhiro
2005
38-39 6 p. 871-887
17 p.
article
76 Endoscopic therapy of early gastric cancer Yamamoto, Hironori
2005
38-39 6 p. 909-926
18 p.
article
77 Endoscopic therapy of lower gastrointestinal cancer Rembacken, B.J.
2005
38-39 6 p. 979-992
14 p.
article
78 Endoscopic treatment of high-grade intraepithelial neoplasia and early cancer in Barrett oesophagus Bergman, Jacques J.G.H.M.
2005
38-39 6 p. 889-907
19 p.
article
79 Endoscopy in gastro-oesophageal reflux disease Hatlebakk, Jan G.
2010
38-39 6 p. 775-786
12 p.
article
80 Endoscopy in the elderly patient de la Mora, Guillermo
2001
38-39 6 p. 999-1012
14 p.
article
81 Ensocopic-endoluminal therapies. A critical appraisal Louis, Hubert
2010
38-39 6 p. 969-979
11 p.
article
82 Enteral and parenteral nutrition in the care of patients with short-bowel syndrome Vanderhoof, Jon A
2003
38-39 6 p. 997-1015
19 p.
article
83 Environmental – Lifestyle related factors Roman, Sabine
2010
38-39 6 p. 847-859
13 p.
article
84 Epidemiology of gallbladder stone disease Shaffer, Eldon A.
2006
38-39 6 p. 981-996
16 p.
article
85 Epidemiology of gastroenteropancreatic neuroendocrine tumours Fraenkel, M.
2012
38-39 6 p. 691-703
13 p.
article
86 Epidemiology of oesophagogastric cancer Lambert, R.
2007
38-39 6 p. 921-945
25 p.
article
87 Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic) Tazuma, Susumu
2006
38-39 6 p. 1075-1083
9 p.
article
88 Erratum 2000
38-39 6 p. 1075-
1 p.
article
89 Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments Hunt, Richard H.
2002
38-39 6 p. 869-883
15 p.
article
90 Expected developments in hepatology Forns, Xavier
2002
38-39 6 p. 957-970
14 p.
article
91 Experimental approaches: dietary and hormone therapy Jeppesen, P.B
2003
38-39 6 p. 1041-1054
14 p.
article
92 Facts and fantasies in extra-oesophageal symptoms in GORD Labenz, J.
2010
38-39 6 p. 893-904
12 p.
article
93 Functional disorders of the gastrointestinal tract: Cost effectiveness review Mapel, Douglas W.
2013
38-39 6 p. 913-931
19 p.
article
94 Future developments in endoscopic imaging Fockens, Paul
2002
38-39 6 p. 999-1012
14 p.
article
95 Future treatment options for HCV: Double, triple, what is the optimal combination? Kronenberger, Bernd
2008
38-39 6 p. 1123-1136
14 p.
article
96 Gallstone disease: primary and secondary prevention Venneman, Niels G.
2006
38-39 6 p. 1063-1073
11 p.
article
97 Gastric acid secretion: Changes during a century Di Mario, Francesco
2014
38-39 6 p. 953-965
13 p.
article
98 Gastric and duodenal neuroendocrine tumours O'Toole, Dermot
2012
38-39 6 p. 719-735
17 p.
article
99 Gastric MALT lymphoma – Update on diagnosis and treatment Fischbach, Wolfgang
2014
38-39 6 p. 1069-1077
9 p.
article
100 Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) de Herder, Wouter W.
2012
38-39 6 p. 689-690
2 p.
article
101 Gastrointestinal bleeding in the elderly Lingenfelser, Thomas
2001
38-39 6 p. 963-982
20 p.
article
102 Gastrointestinal endoscopy in the elderly: Current issues Mönkemüller, Klaus
2009
38-39 6 p. 821-827
7 p.
article
103 Gastro-oesophageal reflux disease Sifrim, Daniel
2010
38-39 6 p. 757-758
2 p.
article
104 Generalizability of cost–utility analyses across countries and settings Ginsberg, Gary M.
2013
38-39 6 p. 845-852
8 p.
article
105 Genetics in primary sclerosing cholangitis Folseraas, Trine
2011
38-39 6 p. 713-726
14 p.
article
106 Helicobacter pylori: The balance between a role as colonizer and pathogen Otero, Laura Llorca
2014
38-39 6 p. 1017-1029
13 p.
article
107 Hepatitis B vaccination and prevention of hepatocellular carcinoma Kao, Jia-Horng
2015
38-39 6 p. 907-917
11 p.
article
108 Hepatobiliary, renal and bone complications of intestinal failure Nightingale, Jeremy Mark Darby
2003
38-39 6 p. 907-929
23 p.
article
109 Hepatocellular carcinoma in viral hepatitis: Improving standard therapy Masuzaki, Ryota
2008
38-39 6 p. 1137-1151
15 p.
article
110 Hereditary diffuse gastric cancer – Pathophysiology and clinical management Pinheiro, Hugo
2014
38-39 6 p. 1055-1068
14 p.
article
111 Immunology of hepatitis B and hepatitis C virus infections Boonstra, Andre
2008
38-39 6 p. 1049-1061
13 p.
article
112 Implementation of gastric cancer screening – The global experience Leja, Mārcis
2014
38-39 6 p. 1093-1106
14 p.
article
113 Index 2001
38-39 6 p. I1-I3
nvt p.
article
114 Index 2000
38-39 6 p. I1-I8
nvt p.
article
115 Indications for specific therapy in the rehabilitation of patients with the short-bowel syndrome Wilmore, Douglas W
2003
38-39 6 p. 895-906
12 p.
article
116 Individual risk stratification of gastric cancer: Evolving concepts and their impact on clinical practice Rugge, Massimo
2014
38-39 6 p. 1043-1053
11 p.
article
117 Intervening in disease through genetically-modified bacteria Ferreira, Adilson K.
2017
38-39 6 p. 693-697
article
118 Intervention in gastro-enteropancreatic neuroendocrine tumours Baudin, Eric
2012
38-39 6 p. 855-865
11 p.
article
119 Intestinal absorption in health and disease: micronutrients Basu, Tapan K
2003
38-39 6 p. 957-979
23 p.
article
120 Intestinal absorption in health and disease—sugars Wright, Ernest M.
2003
38-39 6 p. 943-956
14 p.
article
121 Intestinal epithelial pathobiology: past, present and future Gewirtz, Andrew T.
2002
38-39 6 p. 851-867
17 p.
article
122 Intestinal microbiome and permeability in patients with autoimmune hepatitis Cai, Wangfeng
2017
38-39 6 p. 669-673
article
123 Introduction to health economics and decision-making: Is economics relevant for the frontline clinician? Goeree, Ron
2013
38-39 6 p. 831-844
14 p.
article
124 Is stomach spontaneously ageing? Pathophysiology of the ageing stomach Salles, Nathalie
2009
38-39 6 p. 805-819
15 p.
article
125 Is there an optimal macronutrient mix for weight loss and weight maintenance? Wilkinson, Dana Lee
2004
38-39 6 p. 1031-1047
17 p.
article
126 Laboratory based investigations for diagnosing gastroesophageal reflux disease Dolder, Mathias
2010
38-39 6 p. 787-798
12 p.
article
127 Lifestyle alters GUT-bacteria function: Linking immune response and host Jazayeri, Omid
2017
38-39 6 p. 625-635
article
128 Liver disorders in the elderly Floreani, Annarosa
2009
38-39 6 p. 909-917
9 p.
article
129 Liver transplantation in autoimmune liver diseases Ilyas, Jawad A.
2011
38-39 6 p. 765-782
18 p.
article
130 Liver transplantation in viral hepatitis: Prevention of recurrence Roche, Bruno
2008
38-39 6 p. 1153-1169
17 p.
article
131 Liver transplantation of patients in end-stage cirrhosis Haydon, Geoffrey H.
2000
38-39 6 p. 1049-1073
25 p.
article
132 Management of common bile-duct stones and associated gallbladder stones: surgical aspects Boerma, Djamila
2006
38-39 6 p. 1103-1116
14 p.
article
133 Management of intrahepatic stones Mori, Toshiyuki
2006
38-39 6 p. 1117-1137
21 p.
article
134 Medical and endoscopic therapy of primary sclerosing cholangitis Weismüller, Tobias J.
2011
38-39 6 p. 741-752
12 p.
article
135 Medical treatment of GORD. Emerging therapeutic targets and concepts Zerbib, Frank
2010
38-39 6 p. 937-946
10 p.
article
136 Medical treatment of portal hypertension Garcı́a-Pagán, Juan Carlos
2000
38-39 6 p. 895-909
15 p.
article
137 Methodological considerations for surveillance in GI practice Holme, Øyvind
2016
38-39 6 p. 867-878
12 p.
article
138 Microbiome measurement: Possibilities and pitfalls Radjabzadeh, Djawad
2017
38-39 6 p. 619-623
article
139 Microbiome, pattern recognition receptor function in health and inflammation Fawkner-Corbett, David
2017
38-39 6 p. 683-691
article
140 Microlithiasis and sludge Jüngst, Christoph
2006
38-39 6 p. 1053-1062
10 p.
article
141 Minimally invasive surgery for early lower GI cancer Bemelman, W.A.
2005
38-39 6 p. 993-1005
13 p.
article
142 Modelling the long-term outcomes of bariatric surgery: A review of cost-effectiveness studies Wang, Bruce C.M.
2013
38-39 6 p. 987-995
9 p.
article
143 Modern, new pharmacotherapy for obesity. A gastrointestinal approach Van Gaal, L.
2004
38-39 6 p. 1049-1072
24 p.
article
144 Mortality and economics in short bowel syndrome Schalamon, J
2003
38-39 6 p. 931-942
12 p.
article
145 Multimodal treatment of gastric cancer Moehler, Markus
2007
38-39 6 p. 965-981
17 p.
article
146 Multimodal treatment of oesophageal cancer Veuillez, Véronique
2007
38-39 6 p. 947-963
17 p.
article
147 Multimodal treatment of rectal cancer Glynne-Jones, Rob
2007
38-39 6 p. 1049-1070
22 p.
article
148 NAFLD, Helicobacter species and the intestinal microbiome Castaño-Rodríguez, Natalia
2017
38-39 6 p. 657-668
article
149 Natural history: The importance of viral load, liver damage and HCC Wursthorn, Karsten
2008
38-39 6 p. 1063-1079
17 p.
article
150 Neuroendocrine tumours of the small intestine Strosberg, Jonathan
2012
38-39 6 p. 755-773
19 p.
article
151 New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity Gupta, Rajnish A
2002
38-39 6 p. 945-956
12 p.
article
152 Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course Cortez-Pinto, Helena
2004
38-39 6 p. 1089-1104
16 p.
article
153 Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment Bugianesi, Elisabetta
2004
38-39 6 p. 1105-1116
12 p.
article
154 Non-invasive screening for colorectal cancer in Asia Chiu, Han-Mo
2015
38-39 6 p. 953-965
13 p.
article
155 Nucleos(t)ide analogues for hepatitis B virus: Strategies for long-term success Chien, Rong-Nan
2008
38-39 6 p. 1081-1092
12 p.
article
156 Nutrition and oral health Budtz-Jørgensen, Ejvind
2001
38-39 6 p. 885-896
12 p.
article
157 Nutrition in the elderly Pirlich, Matthias
2001
38-39 6 p. 869-884
16 p.
article
158 Obesity: epidemiology and clinical aspects Formiguera, Xavier
2004
38-39 6 p. 1125-1146
22 p.
article
159 Obesity: surgical options Miller, Karl
2004
38-39 6 p. 1147-1165
19 p.
article
160 Oesophageal disorders: future developments Tam, William
2002
38-39 6 p. 811-833
23 p.
article
161 Organization of surveillance in GI practice Senore, Carlo
2016
38-39 6 p. 855-866
12 p.
article
162 Overview of gastrointestinal cancer prevention in Asia Park, Jong-Min
2015
38-39 6 p. 855-867
13 p.
article
163 Pancreatic cancer: From pathogenesis to cure Ducreux, Michel
2007
38-39 6 p. 997-1014
18 p.
article
164 Pancreatic neuroendocrine tumors: Clinical features, diagnosis and medical treatment: Advances Ito, Tetsuhide
2012
38-39 6 p. 737-753
17 p.
article
165 Pathogenesis of autoimmune hepatitis Liberal, Rodrigo
2011
38-39 6 p. 653-664
12 p.
article
166 Pathogenesis of gallstones: a genetic perspective Grünhage, Frank
2006
38-39 6 p. 997-1015
19 p.
article
167 Pathogenesis of primary sclerosing cholangitis Pollheimer, Marion J.
2011
38-39 6 p. 727-739
13 p.
article
168 Pathology – Grading and staging of GEP-NETs Capelli, Paola
2012
38-39 6 p. 705-717
13 p.
article
169 Pathology of early lower GI cancer Geboes, Karel
2005
38-39 6 p. 963-978
16 p.
article
170 Pathology of early upper GI cancers Vieth, Michael
2005
38-39 6 p. 857-869
13 p.
article
171 Pathophysiology, diagnosis and treatment of ascites in cirrhosis Uriz, Juan
2000
38-39 6 p. 927-943
17 p.
article
172 Peginterferon and ribavirin in HCV: Improvement of sustained viral response Ferenci, P.
2008
38-39 6 p. 1109-1122
14 p.
article
173 Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues Buster, Erik H.C.J.
2008
38-39 6 p. 1093-1108
16 p.
article
174 Peptide receptor radionuclide therapy (PRRT) for GEP-NETs Bergsma, Hendrik
2012
38-39 6 p. 867-881
15 p.
article
175 Perception of gastro-oesophageal reflux Chua, Y.C.
2010
38-39 6 p. 883-891
9 p.
article
176 Perspectives and reflections on integrated digestive surgery Modlin, Irvin M.
2002
38-39 6 p. 885-914
30 p.
article
177 Pharmacological and alimentary alteration of the gastric barrier Boltin, Doron
2014
38-39 6 p. 981-994
14 p.
article
178 Physiology and organ-related pathology of the elderly: stomach ulcers Jones, J.I.W.
2001
38-39 6 p. 943-961
19 p.
article
179 Physiology and pathology of the oesophagus in the elderly patient Lock, Guntram
2001
38-39 6 p. 919-941
23 p.
article
180 Preface Pilotto, Alberto
2009
38-39 6 p. 791-792
2 p.
article
181 Preface Tytgat, G.N.J.
2002
38-39 6 p. vii-
1 p.
article
182 Preface Thomson, A.
2003
38-39 6 p. 877-
1 p.
article
183 Preface van Erpecum, Karel J.
2006
38-39 6 p. 979-980
2 p.
article
184 Preface Clandinin, Tom
2004
38-39 6 p. 1007-
1 p.
article
185 Preface Bergman, J.J.G.H.M.
2005
38-39 6 p. 831-832
2 p.
article
186 Preface Janssen, Harry
2008
38-39 6 p. 989-990
2 p.
article
187 Preface Thomson, A.B.R.
2001
38-39 6 p. vii-
1 p.
article
188 Preface Lau, James Y.W.
2015
38-39 6 p. 841-842
2 p.
article
189 Preface 2000
38-39 6 p. vii-
1 p.
article
190 Preface to “Gut microbiome in health and disease” Peppelenbosch, Maikel P.
2017
38-39 6 p. 605-606
article
191 Prevention of viral hepatitis (B and C) reassessed Van Herck, Koen
2008
38-39 6 p. 1009-1029
21 p.
article
192 Prevention strategies for esophageal cancer: Perspectives of the East vs. West Chung, Chen-Shuan
2015
38-39 6 p. 869-883
15 p.
article
193 Primary sclerosing cholangitis and malignancy Boberg, Kirsten Muri
2011
38-39 6 p. 753-764
12 p.
article
194 Psychological aspects of eating disorders Williamson, Donald A.
2004
38-39 6 p. 1073-1088
16 p.
article
195 Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours Sundin, Anders
2012
38-39 6 p. 803-818
16 p.
article
196 Review: Surveillance of patients with Barrett oesophagus Maes, Sielte
2016
38-39 6 p. 901-912
12 p.
article
197 Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment Freeman, Hugh J.
2004
38-39 6 p. 1167-1175
9 p.
article
198 Screening of gastric cancer in Asia Sugano, Kentaro
2015
38-39 6 p. 895-905
11 p.
article
199 Second look endoscopy in acute non-variceal upper gastrointestinal bleeding Chiu, Philip Wai Yan
2013
38-39 6 p. 905-911
7 p.
article
200 Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours Costa, F.P.
2012
38-39 6 p. 843-854
12 p.
article
201 Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs? Bruley des Varannes, Stanislas
2010
38-39 6 p. 905-921
17 p.
article
202 Small intestinal disorders in the elderly Thomson, Alan B.R.
2009
38-39 6 p. 861-874
14 p.
article
203 Splenomegaly, hypersplenism and coagulation abnormalities in liver disease McCormick, P.Aiden
2000
38-39 6 p. 1009-1031
23 p.
article
204 Surgery for GEP-NETs Knigge, Ulrich
2012
38-39 6 p. 819-831
13 p.
article
205 Surgical approaches and intestinal transplantation Benedetti, Enrico
2003
38-39 6 p. 1017-1040
24 p.
article
206 Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly di Sebastiano, Pierluigi
2009
38-39 6 p. 919-923
5 p.
article
207 Surgical aspects of symptomatic cholecystolithiasis and acute cholecystitis Keus, F.
2006
38-39 6 p. 1031-1051
21 p.
article
208 Surgical strategies for early esophageal adenocarcinoma Stein, H.J.
2005
38-39 6 p. 927-940
14 p.
article
209 Surgical therapy of gastro-oesophageal reflux disease Lundell, Lars
2010
38-39 6 p. 947-959
13 p.
article
210 Surgical treatment of portal hypertension Henderson, J.Michael
2000
38-39 6 p. 911-925
15 p.
article
211 Surveillance after colorectal polyp removal Jover, Rodrigo
2016
38-39 6 p. 937-948
12 p.
article
212 Surveillance after endoscopic and surgical resection of colorectal cancer Sekiguchi, Masau
2016
38-39 6 p. 959-970
12 p.
article
213 Surveillance for hepatocellular carcinoma Díaz-González, Álvaro
2016
38-39 6 p. 1001-1010
10 p.
article
214 Surveillance for neoplasia in the pancreas Overbeek, Kasper A.
2016
38-39 6 p. 971-986
16 p.
article
215 Surveillance in cholangiocellular carcinoma Wirth, Thomas C.
2016
38-39 6 p. 987-999
13 p.
article
216 Surveillance of patients at high-risk of squamous cell esophageal cancer Chaber-Ciopinska, A.
2016
38-39 6 p. 893-900
8 p.
article
217 Surveillance of patients with gastric precancerous conditions Lage, Jorge
2016
38-39 6 p. 913-922
10 p.
article
218 Surveillance of patients with hereditary gastrointestinal cancer syndromes Moreira, Leticia
2016
38-39 6 p. 923-935
13 p.
article
219 Surveillance of patients with inflammatory bowel disease Yu, Jessica X.
2016
38-39 6 p. 949-958
10 p.
article
220 Symptoms and diagnosis of gallbladder stones Portincasa, P.
2006
38-39 6 p. 1017-1029
13 p.
article
221 Symptoms, diagnosis and endoscopic management of common bile duct stones Caddy, Grant R.
2006
38-39 6 p. 1085-1101
17 p.
article
222 Taming the mucosal immune response in Crohn's disease van Deventer, S.J.H.
2002
38-39 6 p. 1035-1043
9 p.
article
223 Targeted screening for colorectal cancer in high-risk individuals Wong, Martin C.S.
2015
38-39 6 p. 941-951
11 p.
article
224 The benefit of animal models for autoimmune hepatitis Jaeckel, Elmar
2011
38-39 6 p. 643-651
9 p.
article
225 The changing epidemiology of Asian digestive cancers: From etiologies and incidences to preventive strategies Wu, Chun-Ying
2015
38-39 6 p. 843-853
11 p.
article
226 The Comprehensive Geriatric Assessment and the multidimensional approach. A new look at the older patient with gastroenterological disorders Pilotto, Alberto
2009
38-39 6 p. 829-837
9 p.
article
227 The current future understanding of inflammatory bowel disease Podolsky, Daniel K.
2002
38-39 6 p. 933-943
11 p.
article
228 The diagnostic and therapeutic approach for primary solid liver tumours in adults Verslype, Chris
2007
38-39 6 p. 983-996
14 p.
article
229 The fight against gastric cancer – the IARC Working Group report Herrero, Rolando
2014
38-39 6 p. 1107-1114
8 p.
article
230 The gastrointestinal microbiome – Functional interference between stomach and intestine Lopetuso, Loris R.
2014
38-39 6 p. 995-1002
8 p.
article
231 The gastrointestinal microbiota and its role in oncogenesis Lam, S.Y.
2017
38-39 6 p. 607-618
article
232 The global challenge of a healthy stomach Bornschein, Jan
2014
38-39 6 p. 949-951
3 p.
article
233 The hepatopulmonary syndrome Aboussouan, Loutfi S
2000
38-39 6 p. 1033-1048
16 p.
article
234 The host–microbe interface within the gut Shanahan, Fergus
2002
38-39 6 p. 915-931
17 p.
article
235 The increasing need for health-economic assessment in gastrointestinal and liver diseases Bardou, Marc
2013
38-39 6 p. 829-830
2 p.
article
236 The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer Van Cutsem, Eric
2007
38-39 6 p. 1089-1108
20 p.
article
237 The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms Orlando, Roy C.
2010
38-39 6 p. 873-882
10 p.
article
238 The multidisciplinary management of gastrointestinal cancer Van Cutsem, Eric
2007
38-39 6 p. 919-920
2 p.
article
239 Therapy of autoimmune hepatitis Strassburg, Christian P.
2011
38-39 6 p. 673-687
15 p.
article
240 The refluxate: The impact of its magnitude, composition and distribution Woodland, Philip
2010
38-39 6 p. 861-871
11 p.
article
241 The relation between body mass and gastro-oesophageal reflux Nilsson, Magnus
2004
38-39 6 p. 1117-1123
7 p.
article
242 The role of delayed gastric emptying and impaired oesophageal body motility Penagini, Roberto
2010
38-39 6 p. 831-845
15 p.
article
243 The role of exercise for weight loss and maintenance Donnelly, Joseph E.
2004
38-39 6 p. 1009-1029
21 p.
article
244 The stomach–brain axis Holtmann, Gerald
2014
38-39 6 p. 967-979
13 p.
article
245 The use of molecular markers in the diagnosis and treatment of colorectal cancer Tejpar, Sabine
2007
38-39 6 p. 1071-1087
17 p.
article
246 Treatment of GERD complications (Barrett’s, peptic stricture) and extra-oesophageal syndromes Bansal, Ajay
2010
38-39 6 p. 961-968
8 p.
article
247 Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies Bardou, Marc
2013
38-39 6 p. 881-892
12 p.
article
248 Understanding and controlling hepatobiliary function Oude Elferink, Ronald P.J.
2002
38-39 6 p. 1025-1034
10 p.
article
249 Understanding and controlling the enteric nervous system Boeckxstaens, G.E.
2002
38-39 6 p. 1013-1023
11 p.
article
250 What is the impact of disease prevalence upon health technology assessment? Rotily, Michel
2013
38-39 6 p. 853-865
13 p.
article
                             250 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands